Regulatory changes and the acceptance of foreign clinical data have fuelled growth of the clinical trial sector in Japan.
Lim Bee Koong
Life Sciences - Clinical
Success in Asia will depend upon the ability of marketers to navigate the local environment with globally developed products.
Companies preparing for the implementation of pharmacoeconomic guidelines in Asia have an opportunity to use those resources for purposes other than justifying government reimbursement.
The pharmaceutical industry needs to revisit its ‘doctorheavy’ marketing strategies to succeed in this continent.
ACNielsen ORG IMS, India
For pharma R&D success in China, the essence is to know how the local environment will support or pose challenges to the characteristics of an effective organisation.
(China) R&D Centre,
and Head of
Biopharma convergence seems to be the panacea for pharma companies struggling with weak R&D productivity and biotech firms facing funding shortfalls.
Pharma Editorial Team
Should it be impossible to exclude the issue of intellectual property from a bilateral negotiation with the USTR, much care should be taken in setting the terms of negotiation.
Costa Rican National
Chamber of Generic
In the coming years, China will become an important player in local and global healthcare, from both provider and utilisation perspectives.
Lee E. Babiss
Fully automated control of fermentation processes on the basis of cell count is now possible in a production environment for the first time.
Director, Head of
Services GmbH, Germany
Micro and nanotechnologies will have a high impact on the pharmaceutical industry making the way to personalized therapy for better treatment efficiency and fewer side effects.
UPLC presents the possibility to extend and expand the utility of conventional HPLC, a widely used separation science.
Waters Corporation, US
Utilising a company that is based in China and understands both ICH GCP and China SFDA GCP requirements is very important for ensuring clinical trial integrity and success.
Nicholas P. Zemo
Development & Sales,
Orally disintegrating tablets are an emerging trend in formulation, gaining popularity due to ease of administration and better patient compliance for geriatric and pediatric patients.
Avani F. Amin
& HOD, Department
Institute of Pharmacy,
Nirma University of
Science & Technology,
RFID is performing functions relevant to pharmaceutical distribution and administration.
The earlier understanding that packaging is not consumed by the end-user, therefore it need not be considered an integral part of the drug, is fast fading off.
Praful R Naik
Digital Pharma will enable lifesciences organisations to improve operations and decision making across the entire industry value chain.
Life Sciences Industry,